-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the increase in the incidence of adverse pregnancy outcomes (APO), the prevalence of obesity in the population is also increasing
.
Quantifying contemporary trends in pre-pregnancy obesity and the association with related APO (premature birth, low birth weight, and pregnancy-related hypertension) can provide information support for optimizing prevention strategies for the cardiometabolic health of women and offspring
prevention
Recently, the heart blood vessels published on the prestigious journal JAHA the areas of disease research article, the researchers used the National Center for Health Statistics birth certificate data conducted a cross-sectional study included between 2013 to 2018 single live births of 15-44 Years old women and stratified by race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, and non-Hispanic Asian)
.
The researchers quantified the annual prevalence of pre-pregnancy obesity (body mass index ≥ 30.
0 kg/m2; if non-Hispanic Asians, body mass index ≥ 27.
5 kg/m2)
.
Then, the researchers used multivariate Logistic regression (odds ratio and population attribution score) to estimate the obesity-related factors compared with normal body mass index (18.
Among the 20139891 women, the prevalence of obesity before pregnancy increased between 2013 and 2018: non-Hispanic whites (21.
6%-24.
8%), non-Hispanic blacks (32.
5%-36.
2%), Hispanics (26.
0 %-30.
5%), and non-Hispanic Asian (15.
3%-18.
6%) women (all P trends <0.
001)
.
The adjusted odds ratio (95% CI) of APO related to obesity increased from 2013 to 2018.
It can be seen that the prevalence of pre-pregnancy obesity and the burden of obesity-related APO have increased, mainly caused by pregnancy-related hypertension, and vary by race/ethnic subgroup
.
.
Original source:
Original source:Michael C.
